Guleken Z, Uzbay T. Neurobiological and
neuropharmacological aspects of food addiction. Neurosci
Biobehav Rev. 2022;139:104760. doi: 10.1016/j.
neubiorev.2022.104760.
2. Barca L, Pezzulo G. Keep your interoceptive streams under
control: an active inference perspective on anorexia nervosa.
Cogn Affect Behav Neurosci. 2020;20(2):427-40. doi:
10.3758/s13415-020-00777-6.
3. Ilyas A, Hübel C, Stahl D, Stadler M, Ismail K, Breen G,
et al. The metabolic underpinning of eating disorders: a
systematic review and meta-analysis of insulin sensitivity.
Mol Cell Endocrinol. 2019;497:110307. doi: 10.1016/j.
mce.2018.10.005.
4. Milos G, Antel J, Kaufmann LK, Barth N, Koller A, Tan S, et
al. Short-term metreleptin treatment of patients with anorexia
nervosa: rapid on-set of beneficial cognitive, emotional, and
behavioral effects. Transl Psychiatry. 2020;10(1):303. doi:
10.1038/s41398-020-00977-1.
5. Mai K, Li L, Wiegand S, Brachs M, Leupelt V, Ernert A, et al.
An integrated understanding of the molecular mechanisms of
how adipose tissue metabolism affects long-term body weight
maintenance. Diabetes. 2019;68(1):57-65. doi: 10.2337/
db18-0440.
6. Guleken Z, Çeçen S, Ceylan Z, Jakubczyk P, Depciuch J.
Application of Fourier transform infrared spectroscopy to
detect biochemical changes in blood serum of obese patients.
J Biophotonics. 2023;16(6):e202200388. doi: 10.1002/
jbio.202200388.
7. Agbu P, Carthew RW. MicroRNA-mediated regulation
of glucose and lipid metabolism. Nat Rev Mol Cell Biol.
2021;22(6):425-38. doi: 10.1038/s41580-021-00354-w.
8. Stadler JT, Lackner S, Mörkl S, Meier-Allard N, Scharnagl H,
Rani A, et al. Anorexia nervosa is associated with a shift to proatherogenic low-density lipoprotein subclasses. Biomedicines.
2022;10(4):895. doi: 10.3390/biomedicines10040895.
9. Ashok T, Puttam H, Tarnate VCA, Jhaveri S, Avanthika C,
Trejo Treviño AG, et al. Role of vitamin B12 and folate in
metabolic syndrome. Cureus. 2021;13(10):e18521. doi:
10.7759/cureus.18521.
10. Corbetta F, Tremolizzo L, Conti E, Ferrarese C, Neri F, Bomba
M, et al. Paradoxical increase of plasma vitamin B12 and
folates with disease severity in anorexia nervosa. Int J Eat
Disord. 2015;48(3):317-22. doi: 10.1002/eat.22371.
11. Barron LJ, Barron RF, Johnson JCS, Wagner I, Ward CJB,
Ward SRB, et al. A retrospective analysis of biochemical and
haematological parameters in patients with eating disorders.
J Eat Disord. 2017;5:32. doi: 10.1186/s40337-017-0158-y.
12. Föcker M, Timmesfeld N, Bühlmeier J, Zwanziger D, Führer D,
Grasemann C, et al. Vitamin D level trajectories of adolescent
patients with anorexia nervosa at inpatient admission,
during treatment, and at one year follow up: association
with depressive symptoms. Nutrients. 2021;13(7):2356. doi:
10.3390/nu13072356.
13. Agbu P, Carthew RW. MicroRNA-mediated regulation
of glucose and lipid metabolism. Nat Rev Mol Cell Biol.
2021;22(6):425-38. doi: 10.1038/s41580-021-00354-w.
14. Schorr M, Miller KK. The endocrine manifestations of anorexia
nervosa: mechanisms and management. Nat Rev Endocrinol.
2017;13(3):174-86. doi: 10.1038/nrendo.2016.175.
15. Shahid MA, Ashraf MA, Sharma S. Physiology, thyroid
hormone. In: StatPearls [Internet]. Treasure Island, FL:
StatPearls Publishing; 2022. Available from: https://www.
ncbi.nlm.nih.gov/books/NBK500006/. Accessed March 26,
2023.
16. Armstrong M, Asuka E, Fingeret A. Physiology, thyroid
function. In: StatPearls [Internet]. Treasure Island, FL:
StatPearls Publishing; 2023. Available from: https://www.
ncbi.nlm.nih.gov/books/NBK537039/. Accessed March 26,
2023.
17. Usdan LS, Khaodhiar L, Apovian CM. The endocrinopathies
of anorexia nervosa. Endocr Pract. 2008;14(8):1055-63. doi:
10.4158/ep.14.8.1055.
18. Glick D, Barth S, Macleod KF. Autophagy: cellular and
molecular mechanisms. J Pathol. 2010;221(1):3-12. doi:
10.1002/path.2697.
19. Leslie M, Lambert E, Treasure J. Towards a translational
approach to food addiction: implications for bulimia nervosa.
Curr Addict Rep. 2019;6(3):258-65. doi: 10.1007/s40429-
019-00264-0.
20. Chen JY, Berner LA, Brown TA, Wierenga CE, Kaye WH.
Associations of elevated weight status with symptom severity
and treatment outcomes in binge/purge eating disorders. Int J
Eat Disord. 2021;54(4):621-6. doi: 10.1002/eat.23446.
21. Monteleone P, Santonastaso P, Pannuto M, Favaro A,
Caregaro L, Castaldo E, et al. Enhanced serum cholesterol
and triglyceride levels in bulimia nervosa: relationships to
psychiatric comorbidity, psychopathology and hormonal
variables. Psychiatry Res. 2005;134(3):267-73. doi: 10.1016/j.
psychres.2004.06.019.
22. Garcez MR, Pereira JL, de Mello Fontanelli M, Marchioni
DM, Fisberg RM. Prevalence of dyslipidemia according
to the nutritional status in a representative sample of São
Paulo. Arq Bras Cardiol. 2014;103(6):476-84. doi: 10.5935/
abc.20140156.
23. Fornari V, Kent J, Kabo L, Goodman B. Anorexia nervosa:
“thirty something”. J Subst Abuse Treat. 1994;11(1):45-54.
doi: 10.1016/0740-5472(94)90063-9.
24. Cuntz U, Voderholzer U. Liver damage is related to the degree
of being underweight in anorexia nervosa and improves
rapidly with weight gain. Nutrients. 2022;14(12):2378. doi:
10.3390/nu14122378.
25. Hirst RB, Beard CL, Colby KA, Quittner Z, Mills BM, Lavender
JM. Anorexia nervosa and bulimia nervosa: a meta-analysis of
executive functioning. Neurosci Biobehav Rev. 2017;83:678-
90. doi: 10.1016/j.neubiorev.2017.08.011.
26. Gearhardt AN, Boswell RG, White MA. The association of
“food addiction” with disordered eating and body mass
index. Eat Behav. 2014;15(3):427-33. doi: 10.1016/j.
eatbeh.2014.05.001.
27. Davis C. A narrative review of binge eating and addictive
behaviors: shared associations with seasonality and
personality factors. Front Psychiatry. 2013;4:183. doi:
10.3389/fpsyt.2013.00183.
28. Guleken Z, Uzbay T. Neurobiological and
neuropharmacological aspects of food addiction. Neurosci
Biobehav Rev. 2022;139:104760. doi: 10.1016/j.
neubiorev.2022.104760.
29. Guleken Z, Ünübol B, Bilici R, Sarıbal D, Toraman S,
Gündüz O, et al. Investigation of the discrimination and
characterization of blood serum structure in patients with
opioid use disorder using IR spectroscopy and PCA-LDA
analysis. J Pharm Biomed Anal. 2020;190:113553. doi:
10.1016/j.jpba.2020.113553.
30. Dickerman AL, Barnhill JW. Abnormal thyroid function
tests in psychiatric patients: a red herring? Am J Psychiatry.
2012;169(2):127-33. doi: 10.1176/appi.ajp.2011.11040631.
31. Lawson EA, Klibanski A. Endocrine abnormalities in anorexia nervosa. Nat Clin Pract Endocrinol Metab. 2008;4(7):407-14.
doi: 10.1038/ncpendmet0872.
32. Centanni M, Maiani G, Vermiglio F, Canettieri G, Sanna
AL, Moretti F, et al. Combined impairment of nutritional
parameters and thyroid homeostasis in mildly iodinedeficient children. Thyroid. 1998;8(2):155-9. doi: 10.1089/
thy.1998.8.155.
33. Leslie RD, Isaacs AJ, Gomez J, Raggatt PR, Bayliss R.
Hypothalamo-pituitary-thyroid function in anorexia nervosa:
influence of weight gain. Br Med J. 1978;2(6136):526-8. doi:
10.1136/bmj.2.6136.526.
34. Spalter AR, Gwirtsman HE, Demitrack MA, Gold PW. Thyroid
function in bulimia nervosa. Biol Psychiatry. 1993;33(6):408-
14. doi: 10.1016/0006-3223(93)90168-d.
35. Kiyohara K, Tamai H, Kobayashi N, Nakagawa T.
Hypothalamic-pituitary-thyroidal axis alterations in bulimic
patients. Am J Clin Nutr. 1988;47(5):805-9. doi: 10.1093/
ajcn/47.5.805.
36. Ural D, Kılıçkap M, Göksülük H, Karaaslan D, KayıkçıoÄŸlu
M, Özer N, et al. [Data on prevalence of obesity and waist
circumference in Turkey: systematic review, meta-analysis and
meta regression of epidemiological studies on cardiovascular
risk factors]. Turk Kardiyol Dern Ars. 2018;46(7):577-90. doi:
10.5543/tkda.2018.62200. [Turkish].
37. Zák A, Vecka M, Tvrzická E, Novák F, Papezová H, Hrubý M,
et al. [Lipid metabolism in anorexia nervosa]. Cas Lek Cesk.
2003;142(5):280-4. [Czech].
38. Stone NJ. Secondary causes of hyperlipidemia. Med Clin
North Am. 1994;78(1):117-41. doi: 10.1016/s0025-
7125(16)30179-1.
39. Hussain AA, Hübel C, Hindborg M, Lindkvist E, Kastrup AM,
Yilmaz Z, et al. Increased lipid and lipoprotein concentrations
in anorexia nervosa: a systematic review and meta-analysis.
Int J Eat Disord. 2019;52(6):611-29. doi: 10.1002/eat.23051.
40. Lala V, Zubair M, Minter DA. Liver Function Tests. In:
StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing;
2022. Available from: https://www.ncbi.nlm.nih.gov/books/
NBK482489/. Accessed March 26, 2023.
41. Rosen E, Bakshi N, Watters A, Rosen HR, Mehler PS.
Hepatic complications of anorexia nervosa. Dig Dis Sci.
2017;62(11):2977-81. doi: 10.1007/s10620-017-4766-9.
42. Narayanan V, Gaudiani JL, Harris RH, Mehler PS. Liver
function test abnormalities in anorexia nervosa--cause or
effect. Int J Eat Disord. 2010;43(4):378-81. doi: 10.1002/
eat.20690.
43. Kistner A, Deschmann E, Legnevall L, Vanpee M. Preterm
born 9-year-olds have elevated IGF-1 and low prolactin,
but levels vary with behavioural and eating disorders. Acta
Paediatr. 2014;103(11):1198-205. doi: 10.1111/apa.12751.
44. Schwetz V, Librizzi R, Trummer C, Theiler G, Stiegler C,
Pieber TR, et al. Treatment of hyperprolactinaemia reduces
total cholesterol and LDL in patients with prolactinomas.
Metab Brain Dis. 2017;32(1):155-61. doi: 10.1007/s11011-
016-9882-2.
45. Broft AI, Berner LA, Martinez D, Walsh BT. Bulimia
nervosa and evidence for striatal dopamine dysregulation: a
conceptual review. Physiol Behav. 2011;104(1):122-7. doi:
10.1016/j.physbeh.2011.04.028.
46. Leaf DE, Bukberg PR, Goldfarb DS. Laxative abuse, eating
disorders, and kidney stones: a case report and review of the
literature. Am J Kidney Dis. 2012;60(2):295-8. doi: 10.1053/j.
ajkd.2012.02.337.
47. Raj KS, Keane-Miller C, Golden NH. Hypomagnesemia in
adolescents with eating disorders hospitalized for medical
instability. Nutr Clin Pract. 2012;27(5):689-94. doi:
10.1177/0884533612446799.
48. Elran-Barak R, Goldschmidt AB, Crow SJ, Peterson CB, Hill
L, Crosby RD, et al. Is laxative misuse associated with binge
eating? Examination of laxative misuse among individuals
seeking treatment for eating disorders. Int J Eat Disord.
2017;50(9):1114-8. doi: 10.1002/eat.22745.